CONSTRUCTION OF RETROVIRAL VECTORS FOR TRANSFERRING HUMAN BILIRUBIN-UDP-GLUCURONOSYLTRANSFERASE GENE - TOWARD GENE-THERAPY FOR CRIGLER-NAJJAR SYNDROME-I

被引：0
|
作者：
ASKARI, F
CHOWDHURY, NR
VANES, HHG
JANSEN, PLM
LEDERSTEIN, M
WILSON, JM
CHOWDHURY, JR
机构：
[1] YESHIVA UNIV ALBERT EINSTEIN COLL MED,MARION BESSIN LIVER RES CTR,BRONX,NY 10461
[2] HOWARD HUGHES MED INST,ANN ARBOR,MI
[3] UNIV AMSTERDAM,ACAD MED CTR,DEPT GASTROENTEROL,1105 AZ AMSTERDAM,NETHERLANDS
来源：
HEPATOLOGY | 1991年 / 14卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
下载
收藏
页码：A126 / A126
页数：1
相关论文
共 38 条
  • [21] A PHENYLALANINE CODON DELETION AT THE UGT1 GENE-COMPLEX LOCUS OF A CRIGLER-NAJJAR TYPE-I PATIENT GENERATES A PH-SENSITIVE BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE
    RITTER, JK
    YEATMAN, MT
    KAISER, C
    GRIDELLI, B
    OWENS, IS
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1993, 268 (31) : 23573 - 23579
  • [22] IN-VIVO GENE-THERAPY FOR BILIRUBIN-UDP-GLUCURONOSYLTRANSFERASE DEFICIENCY - AMELIORATION OF JAUNDICE IN GUNN-RATS AFTER EXSANGUINEOUS PERFUSION OF RECOMBINANT RETROVIRUS
    TADA, K
    PRASAD, VR
    BOSMA, PJ
    HEARD, M
    NEUFIELD, D
    CHOWDHURY, NR
    CHOWDHURY, JR
    GASTROENTEROLOGY, 1995, 108 (04) : A1181 - A1181
  • [23] Direct hepatic injections of HDAd vectors improve the therapeutic index of HDAd for gene therapy of Crigler-Najjar syndrome type 1
    Pastore, N.
    Vetrini, F.
    Nusco, E.
    Palmer, D.
    Ng, P.
    Brunetti-Pierri, N.
    HUMAN GENE THERAPY, 2011, 22 (10) : A46 - A46
  • [24] Transduction with Codon Optimized hUGT1a1 AAV Vectors for More Efficient Crigler-Najjar Syndrome Gene Therapy
    Bortolussi, Giulia
    Collaud, Fanny
    Ronzitti, Giuseppe
    Lacoste, Florence
    Charles, Severine
    Leborgne, Christian
    Vignaud, Alban
    Martin, Samia
    Le Bec, Christine
    Bosma, Piter
    Mavilio, Fulvio
    Mingozzi, Federico
    Muro, Andres
    MOLECULAR THERAPY, 2014, 22 : S226 - S227
  • [25] IDENTIFICATION OF A 2-BASE MUTATION IN THE BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE GENE AT THE UGT1 GENE-COMPLEX LOCUS IN 2 UNRELATED CRIGLER-NAJJAR TYPE-1 PATIENTS
    CIOTTI, M
    OBARAY, R
    MARTIN, M
    OWENS, IS
    FASEB JOURNAL, 1995, 9 (06): : A1267 - A1267
  • [26] Efficient Long Lasting AAV Gene Therapy in a Mouse Model of Crigler-Najjar Syndrome Type I: Coming of Age?
    Bockor, Luka
    Bortolussi, Giulia
    Zentilin, Lorena
    Chiaruttini, Giulia
    Giacca, Mauro
    Benvenuti, Federica
    Muro, Andres F.
    MOLECULAR THERAPY, 2014, 22 : S226 - S226
  • [27] A Step Toward Liver Gene Therapy: Efficient Correction of the Genetic Defect of Hepatocytes Isolated From a Patient With Crigler-Najjar Syndrome Type 1 With Lentiviral Vectors
    Birraux, Jacques
    Menzel, Olivier
    Wildhaber, Barbara
    Jond, Caty
    Nguyen, Tuan Huy
    Chardot, Christophe
    TRANSPLANTATION, 2009, 87 (07) : 1006 - 1012
  • [28] Crigler-Najjar syndrome type II resulting from three different mutations in the bilirubin uridine 5′-diphosphate-glucuronosyltransferase (UGT1A1) gene
    Iolascon, A
    Meloni, A
    Coppola, B
    Rosatelli, MC
    JOURNAL OF MEDICAL GENETICS, 2000, 37 (09) : 712 - 713
  • [29] Rescue of bilirubin-induced neonatal lethality in a mouse model of Crigler-Najjar syndrome type I by AAV9-mediated gene transfer
    Bortolussi, Giulia
    Zentilin, Lorena
    Baj, Gabriele
    Giraudi, Pablo
    Bellarosa, Cristina
    Giacca, Mauro
    Tiribelli, Claudio
    Muro, Andres F.
    FASEB JOURNAL, 2012, 26 (03): : 1052 - 1063
  • [30] Crigler-Najjar syndrome type II in a caucasian patient resulting from two mutations in the bilirubin uridine 5′-diphosphate-glucuronosyltransferase (UGT1A1) gene
    Kraemer, D
    Klinker, H
    JOURNAL OF HEPATOLOGY, 2002, 36 (05) : 706 - 707
1234